Jacobson & Schmitt Advisors’s Pfizer PFE Stock Holding History

Jacobson & Schmitt Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,679	Closed	-$208K	–	66
2023 Q2	$208K	Hold	5,679	–	–	0.06%	61
2023 Q1	$232K	Hold	5,679	–	–	0.07%	55
2022 Q4	$249K	Hold	5,679	–	–	0.08%	44
2022 Q3	$249K	Hold	5,679	–	–	0.08%	44
2022 Q2	$298K	Sell	5,679 -1,025	-15%	-$52.2K	0.09%	41
2022 Q1	$347K	Buy	+6,704	New	+$348K	0.09%	42

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jacobson & Schmitt Advisors's PFE Position: Q3 2023 in Review

Jacobson & Schmitt Advisors sold out of Pfizer (PFE) in Q3 2023, closing a stake of 5,679 shares — an estimated $208K sold.

Jacobson & Schmitt Advisors first reported a position in PFE in Q1 2022 and held it in 6 quarters. The position peaked at $347K in Q1 2022. 2,926 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Jacobson & Schmitt Advisors reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Jacobson & Schmitt Advisors sold 5,679 Pfizer shares in Q3 2023, an estimated $208K.
Jacobson & Schmitt Advisors first reported a position in Pfizer in Q1 2022 and held it in 6 quarters.
Jacobson & Schmitt Advisors's Pfizer position peaked at $347K in Q1 2022.
2,926 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Jacobson & Schmitt Advisors's 13F filing for Q3 2023, filed 7 Nov 2023.